NS Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

Continue Learn More X

Home » News » Company News » Genetesis gets FDA Breakthrough Device Designation for CardioFlux imaging technology » heart-1765298_640(3)

Genetesis gets FDA Breakthrough Device Designation for CardioFlux imaging technology

NS Medical Devices is using cookies

Genetesis’ CardioFlux granted FDA Breakthrough Device Designation. (Credit: Reaper DZ from Pixabay.)

Related Article

Top five cancer start-ups turned scale-ups ranked by investment

RECOMMENDED COMPANIES

MOST READ

Top five cancer start-ups turned scale-ups ranked by investment

Crossing the chasm: How Sky Medical Technology brought its geko device to market

TinyBrains: The new project looking to tackle neonatal brain damage with photonics

New study reveals the rate of depression and anxiety after ICD implantation

Five ways that AI is used in conjunction with medical devices in healthcare

Recommended Whitepaper